Contemporary Antithrombotic Treatment in Patients with Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Rationale and Design of the Greek AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry.
Ioanna XanthopoulouVasiliki-Maria DragonaPeriklis DavlourosCostas TsioufisEfstathios IliodromitisDimitrios Alexopoulosnull nullPublished in: Cardiovascular drugs and therapy (2019)
This study aims at providing "real-world" information on current antithrombotic treatment patterns and clinical outcome of patients with non-valvular AF undergoing PCI.
Keyphrases
- atrial fibrillation
- percutaneous coronary intervention
- oral anticoagulants
- left atrial
- catheter ablation
- left atrial appendage
- direct oral anticoagulants
- heart failure
- st segment elevation myocardial infarction
- acute myocardial infarction
- st elevation myocardial infarction
- antiplatelet therapy
- coronary artery disease
- healthcare
- coronary artery bypass grafting
- replacement therapy
- aortic valve
- left ventricular